|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-5-20
|
|
pubmed:abstractText |
Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor positive (ER+) breast cancer in BRCA1 mutation carriers and to characterize the pathologic features of these tumors.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-11981002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-12412159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-14519755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-15041722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-15930334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-15990899,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-16033833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-17404506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-17597348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-18000219,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-18230721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-18779615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-19147582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-19190334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-19445691,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-19648928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-19733528,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-20346095,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-8564955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9155518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9241077,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9586873,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9652611,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9669814,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9701363,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20149218-9840533
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1465-542X
|
|
pubmed:author |
pubmed-author:CollinsLaura CLC,
pubmed-author:ComanderAmy HAH,
pubmed-author:FettenKatharinaK,
pubmed-author:GallagherBridgetB,
pubmed-author:GarberJudy EJE,
pubmed-author:GelmanRebeccaR,
pubmed-author:KaplanJenniferJ,
pubmed-author:KragKarenK,
pubmed-author:LegareRobert DRD,
pubmed-author:LiHailunH,
pubmed-author:RyanPaula DPD,
pubmed-author:SchnittStuart JSJ,
pubmed-author:SgroiDennisD,
pubmed-author:StoeckertKathryn AKA,
pubmed-author:TungNadineN,
pubmed-author:WangYihongY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
R12
|
|
pubmed:dateRevised |
2010-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:20149218-Adult,
pubmed-meshheading:20149218-Aged,
pubmed-meshheading:20149218-Breast Neoplasms,
pubmed-meshheading:20149218-Case-Control Studies,
pubmed-meshheading:20149218-Female,
pubmed-meshheading:20149218-Genes, BRCA1,
pubmed-meshheading:20149218-Heterozygote,
pubmed-meshheading:20149218-Humans,
pubmed-meshheading:20149218-Middle Aged,
pubmed-meshheading:20149218-Mutation,
pubmed-meshheading:20149218-Receptors, Estrogen,
pubmed-meshheading:20149218-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
|
|
pubmed:affiliation |
Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Brookline Avenue, Boston, MA 02215, USA. ntung@bidmc.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
